GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (Q9V1B2)

Analyse AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (Q9V1B2) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q9V1B2
Type
protein
Length
427 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x1f58318E3C996f6a8937e4709e93051027111758
Molecule
Serine hydroxymethyltransferase
UniProt
Q9V1B2
Pockets
2 · best druggability 0.40

Structure

1 distinct chain · 48% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine hydroxymethyltransferaseprotein42748% helix, 16% strandQ9V1B2

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11160.400.7616empty
21110.390.7519empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.